|
"pan wy"的相關文件
顯示項目 11-35 / 35 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 高雄醫學大學 |
2011 |
2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.
|
陳立宗; Chuang HY;Chang JY;Lai MJ;Kuo CC;Lee HY;Hsieh HP;Chen YJ;Chen LT;Pan WY;Liou JP. |
| 高雄醫學大學 |
2011 |
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors.
|
陳立宗; Kuo CC;Liu TW;Chen LT;Shiah HS;Wu CM;Cheng YT;Pan WY;Liu JF;Chen KL;Yang YN;Chen SN;Chang JY. |
| 臺北醫學大學 |
2011 |
2-Amino-3,4,5-Trimethoxybenzophenones as Potent Tubulin Polymerization Inhibitors
|
Chuang, HY;Chang, JY;Lai, MJ;Kuo, CC;Lee, HY;Hsieh, HP;Chen, YJ;Chen, LT;Pan, WY;Liou, JP |
| 國家衛生研究院 |
2010-05 |
Chamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cells
|
Hsieh, CC;Kuo, YH;Kuo, CC;Chen, LT;Cheung, CHA;Chao, TY;Lin, CH;Pan, WY;Chang, CY;Chien, SC;Chen, TW;Lung, CC;Chang, JY |
| 國家衛生研究院 |
2009-04-17 |
Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents
|
Lai, MJ;Kuo, CC;Yeh, TK;Hsieh, HP;Chen, LT;Pan, WY;Hsu, KY;Chang, JY;Liou, JP |
| 國家衛生研究院 |
2008-02 |
A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells
|
Kao, YH; Hsieh, HP; Chitlimalla, SK; Pan, WY; Kuo, CC; Tsai, YC; Lin, WH; Chuang, SE; Chang, JY |
| 國家衛生研究院 |
2007-07-31 |
Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil
|
Chen, CC; Chen, LT; Tsou, TC; Pan, WY; Kuo, CC; Liu, JF; Yeh, SC; Tsai, FY; Hsieh, HP; Chang, JY |
| 高雄醫學大學 |
2007 |
Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.
|
陳立宗; Chen CC;Chen LT;Tsou TC;Pan WY;Kuo CC;Liu JF;Yeh SC;Tsai FY;Hsieh HP;Chang JY. |
| 國家衛生研究院 |
2006-11 |
Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity
|
Chen, LT;Chen, CC;Tsou, TC;Pan, WY;Kuo, CC;Liu, JF;Yeh, SC;Tsai, FY;Hsieh, HR;Chang, JY |
| 國家衛生研究院 |
2005-12-01 |
Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives
|
Bacherikov, VA; Chang, JY; Lin, YW; Chen, CH; Pan, WY; Dong, H; Lee, RZ; Chou, TC; Su, TL |
| 國家衛生研究院 |
2005-01 |
Four new 6-Nor-5(6 →7)abeo-abietane type diterpenes and antitumoral cytotoxic diterpene constituents from the bark of Taiwania cryptomerioides
|
Chang, CI; Chang, JY; Kuo, CC; Pan, WY; Kuo, YH |
| 國家衛生研究院 |
2004-09 |
Drug design of BPR0L075 as an anticancer agent
|
Hsieh, HP;Liou, JP;Chang, CW;Kuo, CC;Chang, YL;Kuo, FM;Tseng, HY;Pan, WY;Chen, CP;Yang, YN;Chen, CT;Lee, SJ;Chang, JY |
| 國家衛生研究院 |
2004-07-15 |
A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells
|
Juang, SH; Pan, WY; Kuo, CC; Liou, JP; Hung, YM; Chen, LT; Hsieh, HP; Chang, JY |
| 國家衛生研究院 |
2004-07-01 |
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo
|
Kuo, CC; Hsieh, HP; Pan, WY; Chen, CP; Lion, JP; Lee, SJ; Chang, YL; Chen, LT; Chen, CT; Chang, JY |
| 國家衛生研究院 |
2004-07 |
Drug design for BPR0L075 as an anticancer agent
|
Hsieh, HP;Liou, JP;W., CC;Kuo, CC;Chang, YL;Kuo, FM;Tseng, HY;Pan, WY;Chen, CP;Yang, YN;Chen, CT;Lee, SJ;Chang, JY |
| 高雄醫學大學 |
2004 |
A novel bis-benzylidenecyclopentanone derivative; BPR0Y007; inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
|
陳立宗; Juang SH;Pan WY;Kuo CC;Liou JP;Hung YM;Chen LT;Hsieh HP;Chang JY. |
| 高雄醫學大學 |
2004 |
BPR0L075; a novel synthetic indole compound with antimitotic activity in human cancer cells; exerts effective antitumoral activity in vivo.
|
陳立宗; Kuo CC;Hsieh HP;Pan WY;Chen CP;Liou JP;Lee SJ;Chang YL;Chen LT;Chen CT;Chang JY. |
| 國家衛生研究院 |
2003-11-17 |
New analogues of AHMA as potential antitumor agents: Synthesis and biological activity
|
Chang, JY; Lin, CF; Pan, WY; Bacherikov, V; Chou, TC; Chen, CH; Dong, HJ; Cheng, SY; Tasi, TJ; Lin, YW; Chen, KT; Chen, LT; Su, TL |
| 國家衛生研究院 |
2003-07-15 |
Antitumor and antimetastatic activity of IL-23
|
Lo, CH; Lee, SC; Wu, PY; Pan, WY; Su, J; Cheng, CW; Roffler, SR; Chiang, BL; Lee, CN; Wu, CW; Tao, MH |
| 國家衛生研究院 |
2003-06-15 |
Dual inhibition of topoisomerase I and tubulin polymerization by BPR0Y007, a novel cytotoxic agent
|
Chang, JY; Hsieh, HP; Pan, WY; Liou, JP; Bey, SJ; Chen, LT; Liu, JF; Song, JS |
| 臺北醫學大學 |
2003 |
New Analogues of AHMA as Potential Antitumor Agents: Synthesis and Biological activity
|
陳國棟; Chang JY; Lin CF; Pan WY; Bacherikov V; Chou CT; 「CHC; HD; SYC; TJT; YWL; Chen KT; LTC; Su TL*」 |
| 高雄醫學大學 |
2003 |
Dual inhibition of topoisomerase I and tubulin polymerization by BPR0Y007; a novel cytotoxic agent.
|
陳立宗; Chang JY;Hsieh HP;Pan WY;Liou JP;Bey SJ;Chen LT;Liu JF;Song JS. |
| 高雄醫學大學 |
2003 |
New analogues of AHMA as potential antitumor agents: synthesis and biological activity.
|
陳立宗; Chang JY;Lin CF;Pan WY;Bacherikov V;Chou TC;Chen CH;Dong H;Cheng SY;Tasi TJ;Lin YW;Chen KT;Chen LT;Su TL. |
| 國家衛生研究院 |
2002-09-26 |
Antitumor AHMA linked to DNA minor groove binding agents: Synthesis and biological evaluation
|
Rastogi, K; Chang, JY; Pan, WY; Chen, CH; Chou, TC; Chen, LT; Su, TL |
| 高雄醫學大學 |
2002 |
Antitumor AHMA linked to DNA minor groove binding agents: synthesis and biological evaluation.
|
陳立宗; Rastogi K;Chang JY;Pan WY;Chen CH;Chou TC;Chen LT;Su TL |
顯示項目 11-35 / 35 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
